Literature DB >> 17124758

Human embryonic stem cell research: an argument for national research review.

Francois Baylis1, Jason Scott Robert.   

Abstract

The US National Academy of Sciences (NAS) recently published voluntary guidelines for human embryonic stem (hES) cell research. The NAS guidelines propose two levels of oversight. AT the local level, research institutions are to create Embryonic Stem Cell Research Oversight (ESCRO) committees with a mandate to assess the scientific merit and ethical acceptability of hES cell research. At the national level, a new committee is to be created, not to review specific research proposals, but rather to periodically assess, and as needed revise, the NAS guidelines. In this article, we critically assess this proposal. In particular, we review the benefits and limitations of local research review. On this basis, we argue that local review is insufficient for hES cell research and that while there are obvious pragmatic and political reasons for the NAS to favor local research review, there are more compelling reasons for the NAS to have recommended national review of hES cell research proposals.

Entities:  

Keywords:  Analytical Approach; Biomedical and Behavioral Research; Genetics and Reproduction

Mesh:

Year:  2006        PMID: 17124758     DOI: 10.1080/03605300600848136

Source DB:  PubMed          Journal:  Account Res        ISSN: 0898-9621            Impact factor:   2.622


  3 in total

1.  Toward a better bioethics: commentary on "Forbidding science: some beginning reflections".

Authors:  Jason Scott Robert
Journal:  Sci Eng Ethics       Date:  2009-05-07       Impact factor: 3.525

2.  The practical consequences of a national human embryonic stem cell registry.

Authors:  Kenneth Taymor; Christopher Thomas Scott
Journal:  Stem Cell Rev Rep       Date:  2009-09-02       Impact factor: 5.739

3.  Strangers at the benchside: research ethics consultation.

Authors:  Mildred K Cho; Sara L Tobin; Henry T Greely; Jennifer McCormick; Angie Boyce; David Magnus
Journal:  Am J Bioeth       Date:  2008-03       Impact factor: 11.229

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.